ASTEPRO(TM) (azelastine hydrochloride) Nasal Spray Hits U.S. Pharmacies
SOMERSET, N.J., Jan. 15 /PRNewswire/ -- This allergy season, a new medication is available to manage the symptoms of seasonal allergic rhinitis, a condition that impacts as many as 40 million people in the United States. ASTEPRO Nasal Spray contains azelastine in a unique vehicle formulated for enhanced patient benefits. Azelastine is the active ingredient in ASTELIN(R) (azelastine hydrochloride), a leading antihistamine nasal spray. Prescription ASTEPRO(TM) Nasal Spray 137 mcg offers powerful efficacy, rapid relief and improved tolerability. ASTEPRO Nasal Spray is approved by the United States Food and Drug Administration (FDA) for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older.
Seasonal allergic rhinitis can significantly impact quality of life and patients may experience persistent allergy symptoms for many years. ASTEPRO Nasal Spray has demonstrated powerful efficacy in treating the full range of these symptoms, including nasal congestion. It is steroid-free and contains no pseudoephedrine - ingredients sometimes of concern to patients. ASTEPRO Nasal Spray provides rapid symptom relief patients want -- in as early as 30 minutes.
"When pollen counts are at their highest and nasal allergy symptoms erupt, patients simply want effective and fast-acting relief of nasal symptoms including congestion with a well tolerated medication," said Chuck Siegel, M.D., Associate Clinical Professor,
Seasonal allergic rhinitis can cause symptoms that can last for an extended period of time including stuffy or runny nose, sneezing, itchy nose, itchy eyes or watery eyes, an
Copyright©2009 PR Newswire.
All rights reserved